Ambroxol-TEVA (ambroxol hydrochloride) tablets 30 mg. №20

Ambroxol-TEVA (ambroxol hydrochloride) tablets 30 mg. №20

$7.00

Manufacturer: Germany

Purpose: Ambroxol thins mucus, eases coughing, treats respiratory conditions like bronchitis.

SKU: MED56381 Category:

Description

Ambroxol-TEVA (ambroxol hydrochloride) Tablets 30 mg. №20

Ingredients:

Each tablet contains 30 mg of ambroxol hydrochloride.

Mechanism of Action:

Ambroxol-TEVA tablets contain ambroxol hydrochloride, which is a mucolytic agent. It works by thinning and loosening mucus in the airways, facilitating easier expectoration.

Pharmacological Properties:

Ambroxol acts by enhancing the production of pulmonary surfactant, stimulating the activity of serous cells in the bronchial glands, and reducing the adhesiveness of mucus. These actions contribute to the clearance of mucus from the respiratory tract.

Indications for Use:

Ambroxol-TEVA tablets are indicated for the treatment of respiratory conditions associated with excessive mucus production, including acute and chronic bronchitis, asthma, and bronchiectasis.

Contraindications:

Avoid using Ambroxol-TEVA tablets if you have a known allergy to ambroxol or any other components of the product. Consult a healthcare provider before use if you are pregnant or breastfeeding.

Side Effects:

Common side effects of Ambroxol-TEVA tablets may include gastrointestinal disturbances, such as nausea and vomiting. In rare cases, allergic reactions like skin rash or itching may occur. Discontinue use and seek medical advice if you experience severe or persistent side effects.

Usage Instructions:

For adults and children over 12 years old, the recommended dosage is 1 tablet (30 mg) three times a day. Swallow the tablets whole with a glass of water. Do not crush or chew the tablets. Follow the dosage instructions provided by your healthcare provider.

Benefits Compared to Analogues:

Ambroxol-TEVA tablets offer effective mucus clearance and symptom relief in respiratory conditions. Compared to other mucolytic agents, ambroxol has demonstrated superior efficacy in improving lung function and reducing exacerbations in patients with chronic bronchitis.

Suitable Patient Groups:

Ambroxol-TEVA tablets are suitable for adults and children over 12 years old. Consult a healthcare professional for appropriate dosage adjustments in elderly patients or individuals with renal or hepatic impairment.

Storage Conditions and Shelf Life:

  • Store the tablets in a cool, dry place away from direct sunlight.
  • Keep the product out of reach of children.
  • Do not use Ambroxol-TEVA tablets after the expiration date indicated on the packaging.

Packaging Description:

Ambroxol-TEVA tablets are packaged in blister packs containing 20 tablets. The packaging is designed to maintain the stability and integrity of the tablets.

Clinical Evidence and Proven Effectiveness:

Ambroxol has been extensively studied for its efficacy in respiratory conditions. Clinical studies have shown that ambroxol improves lung function, reduces mucus viscosity, and enhances mucociliary clearance. Research published in the International Journal of Chronic Obstructive Pulmonary Disease supports the use of ambroxol in managing chronic bronchitis by reducing exacerbations and improving respiratory symptoms.

Additional Information:

  • Avoid consuming alcohol while taking Ambroxol-TEVA tablets as it may increase the risk of side effects.
  • If you experience any severe or persistent side effects, discontinue use and consult your healthcare provider.

Related products